Clinical trial
DECAMP 1 PLUS: Prediction of Lung Cancer Using Noninvasive Biomarkers
NCT04165564
Study timeline
Study start (actual)2020-08-24Date precision: day
Registry last updated2026-04-01
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Pulmonary Diseaseunresolved
Interventions
Sponsors & collaborators
Boston Universitylead sponsor
Johnson & Johnsoncollaborator
American College of Radiology Imaging Networkcollaborator
Mapped research locations
PhiladelphiaPennsylvania, United States3Los AngelesCalifornia, United States2HoustonTexas, United States1BostonMassachusetts, United States1NashvilleTennessee, United States1ClevelandOhio, United States1PittsburghPennsylvania, United States1BirminghamAlabama, United States1San DiegoCalifornia, United States1Ann ArborMichigan, United States1RochesterMinnesota, United States1BethesdaMaryland, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04165564 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.